Crescent Capital BDC Inc CCAP posted 0.37 per share in net investment income, announced a 50 million buyback and a new joint venture to accelerate leverage reduction amid a subdued LBO market.
Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) โ Live Session & Technical Brief
Updated Nov 22, 2026 5:47 AM ET ยท Prev Close $25.17
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (-0.00%) in Equities
Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) is trading within a tight intraday band at $25.17 (-0.00%, 0.48x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, FCRX is outperforming the S&P 500 by +3.64%. 14-day RSI stands at 62.7, keeping momentum in a bullish regime.
Crescent Capital BDC Inc CCAP posted 0.37 per share in net investment income, announced a 50 million buyback and a new joint venture to accelerate leverage reduction amid a subdued LBO market.
Price ($25.17) holds above both 20-day ($25.10) and 50-day ($25.01) moving averages.
Market & Sector Relative Strength
FCRX outperforming the S&P 500 by +3.64%Recent FCRX Catalyst Headlines
Verified WireAdd-on financings now make up half of Crescent's deal count, a shift that shapes how the firm is working through a slow buyout market.
Buyback and new joint venture unveiled as watch list ticks higher.
Crescent Capital Bdc Nasdaq Ccap reported a slight increase in third-quarter investment income and announced plans to buy back shares and form a joint venture as it works to reduce leverage. Net investment income rose to
1โ3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $25.10 (20-day SMA support) for directional breakout confirmation.
Technical Regime (FCRX)
BULLISH MA TRENDAbout Crescent Capital BDC, Inc. 5.00% Notes due 2026
Get Instant FCRX Catalyst Alerts
Receive an email alert when FCRX triggers an unusual volume breakout, options sweep, or rating shift.
FCRX Session & Catalyst FAQ
Why is FCRX stock trading near flat today?
Crescent Capital BDC, Inc. 5.00% Notes due 2026 (FCRX) is trading within a tight intraday band at $25.17 (-0.00%, 0.48x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, FCRX is outperforming the S&P 500 by +3.64%. 14-day RSI stands at 62.7, keeping momentum in a bullish regime.
Is FCRX stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 0.48x relative volume (low participation). Our multi-factor model currently rates FCRX as BUY. Review full valuation, quality, and timing signals on the FCRX Buy or Sell Decision Brief โ
What is FCRX's intrinsic value and expected trading range?
At $25.17, FCRX's modeled 1-to-3 session range is $24.62 โ $25.72, with a key inflection level at $25.10 (20-day SMA support). Compare current price against multi-year cash flow projections in the FCRX Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for FCRX?
RSI at 62.7 reflects constructive bullish momentum. FCRX trades at $25.17 relative to its 20-day SMA ($25.10) and 50-day SMA ($25.01), reflecting a bullish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.